StockData
Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc. (RYTM) stock

RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)

Close on Nov 17, 2026Market cap $8.03BP/E –Yield –

Rhythm Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Rhythm Pharmaceuticals's price to book ratio was 74.9× on Nov 11, 2026, against 48.9× a year earlier. Over the last 5 years it ranged from 0.7× to 339.9×, with a median of 15.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202674.9×+27.0
2025Dec 31, 202548.0×−258.7
2024Dec 31, 2024306.7×+292.9
2023Dec 29, 202313.8×+8.0
2022Dec 30, 20225.8×+4.2
2021Dec 31, 20211.6×−5.1
2020Dec 31, 20206.7×+1.3
2019Dec 31, 20195.3×+1.9
2018Dec 31, 20183.4×–

More Rhythm Pharmaceuticals figures

See a number that looks wrong?